In the present study, a series of new N-alkyl-N-(piperidin-1-yl)benzenesulfonamide (1a-f) and Naryl/alkyl substitued-2-[(phenylsulfonyl)(piperidin-1-yl)amino]acetamide (3a-n) derivatives were synthesized. These derivatives were prepared by reacting 1-amino piperidine with benzene sulfonyl chloride to afford parent compound N-(piperidin-1-yl)benzenesulfonamide (1), followed by substitution at nitrogen with different electrophilic reagents in the presence of sodium hydride to give a series of derivatives 1a-f and 3a-n. The structures of the synthesized compounds were confirmed based on 1 H-NMR, IR and mass spectral data. The synthesized compounds were screened against acetylcholinesterase (AChE), butyrylcholinesterase (BChE) enzymes and almost all the compounds exhibited promising activities.
INTRODUCTION
The piperidine nucleus is a ubiquitous structural feature of biologically active compounds and numerous secondary metabolites, for example (S)-pipecolic acid a non proteinogenic aminoacid associated with epilepsy (Sanchez-Sancho et al., 1998; Nithiya et al., 2011; Adger et al., 1996 and Daly et al., 1986) . Piperidine bearing compounds have diverse applications in commercial and medicinal area. Piperidine and Pyrrolidine ring containing compounds were evaluated for their effect on plasma glucose level (Kozikowski et al., 1998) . Insulin normalization and treatment of cocaine abuse (Brau et al., 2000) . Sulfonamides are famous for enzyme inhibition such as carbonic anhydrase, cysteine protease, HIV protease and cyclooxygenase (Supuran et al., 2003) . Worldwide [b015] researchers are trying to synthesize new drugs with better pharmacokinetic and dynamic properties with less adverse effects.
Most of the drugs used for the treatment of Alzheimer's disease are acetylcholinesterase inhibitors. Acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) comprise a family of enzymes which include serine hydrolases. The different specificities for substrates and inhibitors for these enzymes are due to the differences in amino acid residues of the active sites of AChE and BChE. The enzyme system is responsible for the termination of acetylcholine at cholinergic synapses. These are key components of cholinergic brain synapses and neuromuscular junctions. The major function of AChE and BChE is to catalyze the hydrolysis of the neurotransmitter acetylcholine and termination of the nerve impulse in cholinergic synapses (Cygler et al., 1993 and Tougu 2001) . It has been found that BChE is present in significantly higher quantities in Alzheimer's plaques than in the normal age related non dementia of brains.
Antagonists of the histamine H 1 and H 2 receptors have been successful as blockbuster drugs for treating allergic conditions and gastric ulcers, respectively. Cholinesterase inhibitors increase the amount of acetylcholine available for neuronal and neuromuscular transmission through their ability to reversibly or irreversibly Hence, the search for new cholinesterase inhibitors is considered an important and ongoing strategy to introduce new drug candidates for the treatment of Alzheimer's disease and other related diseases (Gauthier 2001 and Bertaccini 1982) .
Lipoxygenase enzymes contain iron in their structural frame work and are involved in dioxygenation of lipids, consisting of poly unsaturated fatty acids. Lipoxygenases perform a key role in the synthesis of leukotrienes, which are responsible for pathophysiology of different allergic diseases. Lipoxygenase inhibitors are required to cure these allergic and inflammatory diseases (Roussaki et al., 2010 and Aziz-ur-Rehman et al., 2004) ).
Pharmacological potential of the heterocyclic compounds motivated chemists to synthesize piperidine derivatives with improved biological activities (Li et al., 2007) . In continuation of our previous work on sulfonamides as possible therapeutic entrants (Aziz-ur-Rehman et al., 2011) , here we report the synthesis of new sulfonamides bearing piperidine moiety having talented to moderate inhibitory potential against butyrylcholinesterase enzyme.
MATERIAL AND METHODS

General experimental part
Melting points of the synthesized compounds were recorded on a Griffin and George melting point apparatus by open capillary tube and were uncorrected. Purity was checked on thin layer chromatography (TLC) on pre-coated silica gel G-25-UV 254 plates with different solvent systems using ethyl acetate and n-hexane giving single spot. Detection was carried out at 254 nm, and by ceric sulphate reagent. The I.R. spectra were recorded in KBr pellet method on a Jasco-320-spectrophotometer (wave number in cm -1 ). Nuclear magnetic resonance spectra were recorded in CD 3 OD on a Bruker spectrometers operating at 300 MHz. Chemical shifts are given in ppm. Mass spectra (EIMS) were recorded on a JMS-HX-110 spectrometer, with a data system. 1-aminopiperidine, benzenesulfonyl chloride, bromoacetyl bromide, substituted/ unsubstituted aromatic amines and the other electrophilic reagents were obtained from commercial suppliers. All the employed solvents were of analytical grade.
Procedure for the synthesis of N-(piperidin-1-yl)benzenesulfonamide in aqueous medium (1):
1-amino piperidine (a) (2.6 mL; 10.0 mmol) was suspended in 50 mL water and the pH was maintained at 9.0 by adding basic aqueous solution of a Na 2 CO 3 at 0-5 o C. Then, benzenesulfonyl chloride (b) (2.9 mL; 10.0 mmol) was added in the reaction mass slowly over 10-15-min. After completion of the addition, the temperature of the reaction mixture was allowed to rise slowly to room temperature. The reaction mixture was stirred and monitored with TLC for the completion of reaction. Then conc. HCl (around 2 mL) was added slowly to adjust the pH to 2.0. The reaction mass was cooled to room temperature (RT), filtered and the solid washed with distilled water to afford the title compound 1 on drying.
General procedure for the synthesis of compounds 1a-f:
To a solution of compound 1 (0.2 g, 8.33 mmol) in N,N-dimethyl formamide (DMF) (5 mL) was added sodium hydride (0.01 g, 0.40 mmol) at 0-5 °C. After completion of the addition, the temperature of the reaction mass was raised to RT and stirred for 15 min. The corresponding alkyl halide (8.33 mmol) was added into the reaction mixture and stirred for 30-40 min. The reaction mass was then monitored by TLC. After complete conversion, the reaction mass was cooled to room temperature and quenched with cold water (200 mL). The obtained solid was filtered, washed with water and dried to yield the corresponding N-alkyl derivatives 1a-f.
The corresponding alkyl halides used for the reactions were ethyl iodide, allyl iodide, benzyl chloride, 4-bromobenzyl bromide, 2-phenyl ethyl iodide and 3-phenyl propyl iodide.
General procedure for the synthesis of compounds 2a-n:
The calculated amount of substituted aromatic amines/ aromatic alkyl amines (11.00 mmoles) was taken in an iodine flask containing 10 mL of distilled water and 5% Na 2 CO 3 solution was added to adjust the pH 8.0 to 9.0. After adjusting the pH, the temperature of the reaction mass was acetamide (3a-m) derivatives.
SPECTRAL CHARACTERIZATION OF THE SYNTHESIZED COMPOUNDS:
N-(piperidin-1-yl) benzenesulfonamide (1): 
N-ethyl-N-(piperidin-1-yl) benzenesulfonamide (1a):
IR ( 
N-(3-Methoxyphenyl)-2-[(phenylsulfonyl)(piperidin-1-yl)amino]acetamide (3c):
IR ( 2H, H-2', H-6'), 7.73 (m, 2H, H-3ꞌ, H-5'), 7.61 (m, 1H, H-4'), 7.01 (dd, J = 8.7, 2. 
N-(2,4-dimethylphenyl)-2-[(phenylsulfonyl)(piperidin-1-yl)amino]acetamide (3j):
Acetylcholinesterase assay
The AChE inhibition activity was performed according to the method (Ellman et al., 1961 ) with slight modifications. Total volume of the reaction mixture was 100 µL. It contained 60 µL Na 2 H PO 4 buffer with concentration of 50 mM and pH 7.7. Ten µL test compound (0.5 mM well -1 ) was added, followed by the addition of 10 µL (0.005 unit well -1 ) enzyme. The contents were mixed and pre-read at 405 nm. Then contents were pre-incubated for 10 min at 37ºC. The reaction was initiated by the addition of 10 µL of 0.5 mM well -1 substrate (acetylthiocholine iodide), followed by the addition of 10 µL DTNB (0.5 mM well -1 ). After 15 min of incubation at 37ºC absorbance was measured at 405 nm using 96-well plate reader Synergy HT, Biotek, USA. All experiments were carried out with their respective controls in triplicate. Eserine (0.5 mM well -1 ) was used as a positive control. The percent inhibition was calculated by the help of following equation
IC 50 values were calculated using EZ-Fit Enzyme kinetics software (Perrella Scientific Inc.
Amherst, USA).
Butyrylcholinesterase assay
The BChE inhibition activity was performed addording to the method (Ellman et al., 1961 ) with slight modifications. Total volume of the reaction mixture was 100 µL containing 60 µL, Na 2 H PO 4 buffer, 50 mM and pH 7.7. Ten µL test compound 0.5 mM well -1 was added followed by the addition of 10 µL (0.5 unit well -1 ) BChE (Sigma Inc.). The contents were mixed and pre-read at 405 nm and then pre-incubated for 10 min at 37ºC. The reaction was initiated by the addition of 10 µL of 0.5 mM well -1 substrate (butyrylthiocholine chloride). Followed by the addition of 10 µL DTNB, 0.5 mM well -1 . After 15 min of incubation at 37ºC, absorbance was measured at 405 nm using 96-well plate reader Synergy HT, Biotek, USA. All experiments were carried out with their respective controls in triplicate. Eserine (0.5 mM well -1 ) was used as positive control. The percent inhibition was calculated by the help of following equation.
Lipoxygenase assay
Lipoxygenase (LOX) activity was assayed addording to the method (Tappel 1953; Evans 1987 and Baylac et al., 2003) with slight modifications. A total volume of 200 µL lipoxygenase assay mixture contained 150 µL sodium phosphate buffer (100 mM, pH 8.0), 10 µL test compound and 15 µL purified lipoxygenase enzyme (600 units well -1 ,Sigma Inc.). The contents were mixed and pre-read at 234 nm and preincubated for 10 minutes at 25°C. The reaction was initiated by addition of 25 µL substrate solution. The change in absorbance was observed after 6 min at 234 nm using 96-well plate reader Synergy HT, Biotek, USA. All reactions were performed in triplicates. The positive and negative controls were included in the assay. Baicalin (0.5 mM well -1 ) was used as a positive control. The percentage inhibition (%) was calculated by formula given below.
Where Control = Total enzyme activity without inhibitor Test = Activity in the presence of test compound IC 50 values was calculated using EZ-Fit Enzyme Kinetics software (Perrella Scientific Inc.
Statistical Analysis
All the measurements were done in triplicate and statistical analysis was performed by Microsoft Excel 2003. Results are presented as mean ± sem.
RESULTS AND DISCUSSION
In the undertaken research, a series of heterocyclic compounds containing piperidine nucleus was synthesized as scheme-1. The parent compound N-(piperidin-1-yl)benzenesulfonamide (1), was prepared by a process similar to the known literature procedure (Deng et al., 2006 and Jafarpour et al., 2011) Similarly, the structure of other compounds was characterized by 1 H-NMR, IR and mass spectral data as described in experimental section. The physical data of all the synthesized compounds has been shown in table-1.
Pharmacology
The screening of these synthesized compounds against acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and lipoxygenase (LOX) enzymes revealed that these molecules exhibited good inhibitory potential against acetylcholinesterase and butyrylcholinesterase as it was evident from their IC 50 values. It is obvious from Table-2 
CONCLUSION:
The proposed structures of the synthesized compounds are well supported by spectroscopic data.
From the enzyme inhibition data ( 
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